MTIF2
Translation initiation factor IF-2, mitochondrial
Also known as: IF-2mt, IF2M_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46199
- Gene
- MTIF2
- Ensembl
- ENSG00000085760
- Chromosome
- 2
- Canonical length
- 727 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
During the initiation of protein biosynthesis, initiation factor-2 (IF-2) promotes the binding of the initiator tRNA to the small subunit of the ribosome in a GTP-dependent manner. Prokaryotic IF-2 is a single polypeptide, while eukaryotic cytoplasmic IF-2 (eIF-2) is a trimeric protein. Bovine liver mitochondria contain IF-2(mt), an 85-kD monomeric protein that is equivalent to prokaryotic IF-2. The predicted 727-amino acid human protein contains a 29-amino acid presequence. Human IF-2(mt) shares 32 to 38% amino acid sequence identity with yeast IF-2(mt) and several prokaryotic IF-2s, with the greatest degree of conservation in the G domains of the proteins. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
727 residues, UniProt reviewed canonical sequence.
>P46199|MTIF2
1 MNQKLLKLEN LLRFHTIYRQ LHSLCQRRAL RQWRHGFSSA YPVWTAQLCA WPWPTDVLTG
61 AALSQYRLLV TKKEEGPWKS QLSSTKSKKV VEVWIGMTIE ELARAMEKNT DYVYEALLNT
121 DIDIDSLEAD SHLDEVWIKE VITKAGMKLK WSKLKQDKVR KNKDAVRRPQ ADPALLTPRS
181 PVVTIMGHVD HGKTTLLDKF RKTQVAAVET GGITQHIGAF LVSLPSGEKI TFLDTPGHAA
241 FSAMRARGAQ VTDIVVLVVA ADDGVMKQTV ESIQHAKDAQ VPIILAVNKC DKAEADPEKV
301 KKELLAYDVV CEDYGGDVQA VPVSALTGDN LMALAEATVA LAEMLELKAD PNGPVEGTVI
361 ESFTDKGRGL VTTAIIQRGT LRKGSVLVAG KCWAKVRLMF DENGKTIDEA YPSMPVGITG
421 WRDLPSAGEE ILEVESEPRA REVVDWRKYE QEQEKGQEDL KIIEEKRKEH KEAHQKAREK
481 YGHLLWKKRS ILRFLERKEQ IPLKPKEKRE RDSNVLSVII KGDVDGSVEA ILNIIDTYDA
541 SHECELELVH FGVGDVSAND VNLAETFDGV IYGFNVNAGN VIQQSAAKKG VKIKLHKIIY
601 RLVEDLQEEL SSRLPCAVEE HPVGEASILA TFSVTEGKKK VPVAGCRVQK GQLEKQKKFK
661 LTRNGHVIWK GSLTSLKHHK DDISIVKTGM DCGLSLDEDN MEFQVGDRIV CYEEKQIQAK
721 TSWDPGFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTIF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- tongue: 46 nTPM
- skeletal muscle: 41 nTPM
- liver: 31 nTPM
- heart muscle: 30 nTPM
- rectum: 30 nTPM
- colon: 26 nTPM
Single-cell type
- thymic myoid cells: 56 nCPM
- erythrocyte progenitors: 55 nCPM
- esophageal basal cells: 55 nCPM
- megakaryocyte-erythroid progenitors: 50 nCPM
- esophageal suprabasal cells: 50 nCPM
- myonuclei: 50 nCPM
Immune cell
- NK-cell: 17 nTPM
- myeloid DC: 14 nTPM
- intermediate monocyte: 13 nTPM
- T-reg: 12 nTPM
- MAIT T-cell: 12 nTPM
- naive CD8 T-cell: 12 nTPM
Brain region
- choroid plexus: 29 nTPM
- white matter: 26 nTPM
- hypothalamus: 25 nTPM
- thalamus: 25 nTPM
- cerebellum: 24 nTPM
- medulla oblongata: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MTIF2.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 129 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.3
- DepMap mean gene effect
- -0.35
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- formation of translation preinitiation complex
- mitochondrial translational initiation
- ribosome disassembly
Molecular functions
- GTP binding
- GTPase activity
- ribosomal small subunit binding
- RNA binding
- translation factor activity, RNA binding
- translation initiation factor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translational (tr)-type GTP-binding domain
- Small GTP-binding domain
- Translation protein, beta-barrel domain superfamily
- Translation initiation factor IF- 2
- Translation initiation factor IF- 2, domain 3
- P-loop containing nucleoside triphosphate hydrolase
- Translation initiation factor IF-2, domain 3 superfamily
- Elongation factor G-like, domain II
- Elongation factor Tu GTP binding domain
- Translation-initiation factor 2
- Elongation factor G domain 2
- Translation initiation factor IF-2, bacterial-like
- Translation initiation factor IF-2, domain II
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MTIF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTIF2 as an antibody target. Whether an autoantibody or antibody against MTIF2 could matter depends on whether native MTIF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTIF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTIF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...